Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Bristol Myers sues AstraZeneca over cancer-treatment patents
Reuters
Mon, 03/21/22 - 10:08 am
Tags:
Bristol Myers Squibb, AstraZeneca, cancer, patents, legal
AstraZeneca prepared to ditch effort to secure US approval for Covid vaccine
Financial Times
Thu, 03/17/22 - 11:35 pm
Tags:
AstraZeneca, vaccines, COVID-19
After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
Fierce Pharma
Thu, 03/17/22 - 10:38 am
Tags:
AstraZeneca, Roche, Chugai, Ultomiris, patents
AstraZeneca throws open doors to new ideas in global postdoc challenge
Fierce Biotech
Thu, 03/17/22 - 10:32 am
Tags:
AstraZeneca, R&D
FDA clears first generic of AZ’s blockbuster Symbicort
Pharmaforum
Wed, 03/16/22 - 10:21 am
Tags:
Viatris, AstraZeneca, generics, FDA, Symbicort
FDA clears AstraZeneca, Merck drug to treat some genetic breast cancers early
BioPharma Dive
Mon, 03/14/22 - 10:26 am
Tags:
AstraZeneca, Merck, Lynparza, genetic breast cancer, FDA
FDA says no to AZ’s Fasenra for nasal polyp indication
Pharmaforum
Mon, 03/14/22 - 10:19 am
Tags:
AstraZeneca, Fasenra, nasal polyps
Ukraine pharma CEO urges the industry to rally behind his country on three fronts
Fierce Pharma
Mon, 03/7/22 - 11:19 pm
Tags:
Ukraine, Russia, biotech, AstraZeneca
AstraZeneca to tack on another $100M to wrap up over-budget R&D center
Fierce Biotech
Mon, 03/7/22 - 10:42 am
Tags:
AstraZeneca, R&D, UK
Eli Lilly, Boehringer Ingelheim's Jardiance turns up heat on AstraZeneca's Farxiga with broad EU heart failure approval
Fierce Pharma
Mon, 03/7/22 - 10:10 am
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, heart failure, Europe, AstraZeneca, Farxiga
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line
Fierce Pharma
Thu, 03/3/22 - 10:33 am
Tags:
FDA, drug approvals, FibroGen, AstraZeneca, daprodustat, Bristol Myers Squibb, Opdivo, Roche, tiragolumab, Merck, favezelima, bInnovent, Eli Lilly, Akeso Biopharma, Sino Biopharmaceutical, Novartis, Ukoniq, TG Therapeutics, GW Pharmaceuticals, Marinus Pharmaceuticals
Sanofi, AstraZeneca Express Optimism Over Phase III Infant RSV Results
BioSpace
Thu, 03/3/22 - 10:24 am
Tags:
Sanofi, AstraZeneca, nirsevimab, vaccines, RSV, clinical trials
Rare disease and neurology take outs tick higher
EP Vantage
Wed, 03/2/22 - 10:03 am
Tags:
M&A, AbbVie, AstraZeneca, Bristol Myers Squibb, JNJ, Gilead Sciences, Jazz Pharmaceuticals, Merck, Pfizer, Sanofi, rare disease, neurology
AstraZeneca faces $278M Imfinzi patent infringement lawsuit from co-developer Ono
Fierce Pharma
Tue, 03/1/22 - 10:32 am
Tags:
AstraZeneca, Ono Pharmaceutical, lung cancer, patents, Imfinzi
AstraZeneca and Neurimmune close agreement to develop monoclonal antibody, NI006
Biopharma Reporter
Tue, 03/1/22 - 10:23 am
Tags:
Alexion, AstraZeneca, Neurimmune, N!006, monoclonal antibodies, transthyretin amyloid cardiomyopathy
AstraZeneca doubles down on animation—with a '60s spin this time—in new Breztri ad campaign
Fierce Pharma
Mon, 02/28/22 - 09:17 am
Tags:
AstraZeneca, Breztri, television ads, DTC ads
It looks like the final round of Emergent's AstraZeneca Covid-19 doses have been released
Endpoints
Tue, 02/22/22 - 11:12 pm
Tags:
Emergent BioSolutions, AstraZeneca, COVID-19, vaccines
AstraZeneca CEO snared more than $18M last year as his company worked through highs and lows of vaccine launch
Fierce Pharma
Tue, 02/22/22 - 10:56 am
Tags:
AstraZeneca, Pharma CEOs, executive pay, Pascal Soriot, pandemic, COVID-19
Big day for AZ, Daiichi as Enhertu aces HER2-low breast cancer trial
Pharmaforum
Mon, 02/21/22 - 10:35 am
Tags:
AstraZeneca, Daiichi Sankyo, Enhertu, clinical trials, HER2-low breast cancer, breast cancer
Roche and AstraZeneca settle years long patent battle over Ultomiris — report
Endpoints
Sun, 02/20/22 - 11:48 am
Tags:
Roche, Chugai, AstraZeneca, Alexion, patents, Ultomiris, Soliris

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.